Abstract B023: Identifying therapeutic vulnerabilities in metastatic prostate cancer transcriptional phenotypesDavid A. Gallo, Marina N. Sharifi, Viridiana Carreno et al.|Cancer Research|2026Cited by 0
Abstract A030: Lossless altered histone modification analysis system to investigate patient derived cancer organoids and circulating tumor cells from patients with prostate cancerZachary J. Kauffman, Joshua M. Lang, Kevin Koesser et al.|Cancer Research|2026Cited by 0